Select Page

The Infinium Global Research analyzes the Single-Cell Analysis Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size, and future trends in the global single-cell analysis market. It will help a lot of decision-makers to develop strategies and find new opportunities in the global markets of single-cell analysis. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the single-cell analysis market during the period.

“We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.”

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report:

Single-cell analysis is a rapidly developing approach to characterize genome-scale molecular information at the individual cell level. The development of single-cell technologies and computational methods has enabled systematic investigation of cellular heterogeneity in a wide range of drug development and disease studies.

Growing Number of Biotechnology and Pharmaceutical Industries Worldwide Primarily Drives the Growth of the Single-Cell Analysis Market

The growing number of biotechnology and pharmaceutical industries worldwide primarily drives the growth of the single-cell analysis market. Single-cell analysis is used in wide applications such as cancer research, stem cell research, neuroscience, stem cell biology, developmental biology, and infectious disease. In addition, the global single-cell analysis is driven by factors such as increasing incidence and prevalence of chronic and infectious diseases, technological advancements in single-cell analysis products, growing emphasis on personalized medicine, and increasing government funding for cell-based research.

However, several conventional single-cell analysis tools are not robust or reliable as well as the high cost of single-cell analysis products restrains the growth of the single-cell analysis market. Moreover, growing clinical research and the use of single-cell analysis in diagnosis, prognosis, and treatment of a broad range of diseases and medical conditions provides several beneficial opportunities for the growth of the single-cell analysis market.

Enquire Here Get Customization & Check Discount for Report @

Single-cell Analysis Market: Segmentation

The global single-cell analysis market is segmented on the basis of product type, applications, and end-users. The product types include instruments and consumables. The instruments in the single-cell analysis market are further segmented into Microarray Systems, Flow Cytometers, Microscopes, NGS Systems, PCR Instruments, Spectrophotometers, and HCS Systems. The consumables are further bifurcated into reagents, assay kits, and other consumables.

The applications include cancer, immunology, neurology, stem cell, non-invasive prenatal diagnosis, and in-vitro fertilization. Among them, cancer holds the largest share in the single-cell analysis market. Single-cell transcriptome analyses have been extensively used to understand the heterogeneity of tumors, classifying tumors into molecular subtypes, and establishing signatures that predict response to therapy and patient outcomes.

The end-user is further classified into biotechnology and pharmaceutical companies, hospitals, diagnostic laboratories, academic & research laboratories, and other end-users. Among the end-users, biotechnology and pharmaceutical companies hold the largest share in the single-cell analysis market as single-cell analytic tools are being increasingly used for drug discovery and development in these industries.

North America Holds the Largest Share in the Global Single-Cell Analysis Market

Globally, North America holds the largest share in the global single-cell analysis market. Factors such as growing incidences of cancer, rising geriatric population with high disposable income, supportive government policies, and high investments in the biotechnological establishments contribute to the largest revenue in the North America single-cell analysis market. Furthermore, the Asia Pacific region is also anticipated to be a leading revenue contributor in the global single-cell analysis market over the forecast period. The rapid increase in the aging population and increasing incidence of chronic diseases in countries such as India and China and growing technological advancements in the Asia Pacific medical sector are fueling the growth of the single-cell analysis market.

Single-cell Analysis Market: Competitive Analysis

The single-cell analysis market is an emerging market. major players in the global single-cell analysis market are Bio-Rad Laboratories, Inc., Fluidigm Corporation, Merck Group, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, Becton, Dickinson and Company, Illumina, Inc., Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation) and Qiagen N.V.

Browse Detailed TOC, Description, and Companies Mentioned in Report @

About Us

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.